JADPRO | Homepage

Beyond Standard Endocrine Therapy: A New Adjuvant Treatment in High-Risk Early Breast Cancer

Barbara Dean, DMSc, PA-C, DFAAPA

July 22, 2024

14 min read

Diversity, Equity, and Inclusion in Multiple Myeloma: A Call to Action

Rebecca Lu, MSN, FNP-C, Joseph D. Tariman, PhD, MBA, ANP-BC, FAAN, Donna Catamero, ANP-BC, OCN, CCRC, Et al.

July 22, 2024

27 min read

Translating Research Into Practice

A Real-World Evidence Primer for Advanced Practice Providers: Integrating P-Reality X Into Shared Decision-Making for People With HR+/HER2− Metastatic Breast Cancer

Sarah Donahue, MPH, NP, Joanne C. Ryan, PhD, RN, Kimberly Podsada, MSN, NP-C Et al.

July 22, 2024

29 min read

Practical Management of Adverse Events Associated With FGFR Inhibitors for Cholangiocarcinoma for the Advanced Practice Provider

Review Article

Practical Management of Adverse Events Associated With FGFR Inhibitors for Cholangiocarcinoma for the Advanced Practice Provider

Gabriel Schwartz, MSN, FNP-BC, AOCNP,Julianne O. Darling, PharmD, BCOP

Cholangiocarcinoma is a cancer of the bile duct frequently diagnosed at a late stage with a poor prognosis. Selective fibroblast growth f...

Online First (2024)

32 min read

A Real-World Evidence Primer for Advanced Practice Providers: Integrating P-Reality X Into Shared Decision-Making for People With HR+/HER2− Metastatic Breast Cancer

Translating Research Into Practice

A Real-World Evidence Primer for Advanced Practice Providers: Integrating P-Reality X Into Shared Decision-Making for People With HR+/HER2− Metastatic Breast Cancer

Sarah Donahue, MPH, NP,Joanne C. Ryan, PhD, RN,Kimberly Podsada, MSN, NP-CEt al.

Online First (2024)

29 min read

Improving Practice in a Head and Neck Oncology Clinic Using the PRO-CTCAE Tool

Research and Scholarship

Improving Practice in a Head and Neck Oncology Clinic Using the PRO-CTCAE Tool

Rose Ann Ruddy,(1) DNP, MSN, RN, ACNP-BC, Brigit Carter,(2) PhD, RN, CCRN, FAAN, Maryanne Giuliante,(1) DNP, MBA, RN, GNP, ANP-C, NEA-BC, HEC-C, and AnnMarie Lee Walton,(2) PhD, RN, MPH, OCN®, CHES, FAAN

Volume 15, Number 5 (Jul/Aug 2024)

22 min read

Breast Cancer Colorectal Cancer Gastrointestinal Cancer Lung Cancer Prostate Cancer Multiple Myeloma Lymphoma Palliative Care CAR T-Cell Therapy Immunotherapy

Editorial

Artificial Intelligence: How Is it Relevant to Advanced Practitioners?

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

July 19, 2024

5 min read

Research and Scholarship

Improving Practice in a Head and Neck Oncology Clinic Using the PRO-CTCAE Tool

Rose Ann Ruddy,(1) DNP, MSN, RN, ACNP-BC, Brigit Carter,(2) PhD, RN, CCRN, FAAN, Maryanne Giuliante,(1) DNP, MBA, RN, GNP, ANP-C, NEA-BC, HEC-C, and AnnMarie Lee Walton,(2) PhD, RN, MPH, OCN®, CHES, FAAN

July 19, 2024

22 min read

Review Article

Interaction of the Gut Microbiome With Cancer Treatment

Paula M. Barrenechea, MPAS, PA-C

July 19, 2024

25 min read

Grand Rounds

Carcinoid Heart Disease

Nicole Ross, MSN, CRNP, AOCNP

July 19, 2024

9 min read

JADPRO Expert Conversations

Expert Conversations

JADPRO Expert Conversations

Go behind the scenes and learn from one-on-one conversations between expert advanced practitioners as they discuss the latest data and proven real-world approaches to oncology care.

Learn More

Multiple Myeloma Resource Center

Resource Centers

Multiple Myeloma Resource Center

What Advanced Practitioners Need to Know About BCL-2 Inhibition in CLL

Roundtable Series

What Advanced Practitioners Need to Know About BCL-2 Inhibition in CLL

Renal Cell Carcinoma Resource Center

Resource Centers

Renal Cell Carcinoma Resource Center

Live Events

JADPRO Live

Join us for our 12th annual conference, happening November 14-17, 2024, in Grapevine, Texas

Learn More

Webinars

Second-Line CAR T-Cell Therapy for Multiple Myeloma

JADPRO Clinical Case Series

Second-Line CAR T-Cell Therapy for Multiple Myeloma

Cytopenias, Including Transfusion-Dependent Anemia, in Myelofibrosis

JADPRO Clinical Case Series

Cytopenias, Including Transfusion-Dependent Anemia, in Myelofibrosis

Bispecific Antibodies in DLBCL: Navigating the Evolving Treatment Landscape

JADPRO Clinical Case Series

Bispecific Antibodies in DLBCL: Navigating the Evolving Treatment Landscape